CG
SNDX icon

Cutler Group’s Syndax Pharmaceuticals SNDX Stock Holding History

Cutler Group’s Portfolio SNDX Stock Details SNDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-1,500
Closed -$33K – 6285
2021
Q1 		$33K Buy
1,500
+500
+50% +$11.3K ﹤0.01% 2753
2020
Q4 		$22K Buy
+1,000
New +$20.7K ﹤0.01% 2628
2020
Q1 		– Sell
-3,300
Closed -$28K – 4595
2019
Q4 		$28K Buy
+3,300
New +$24.2K ﹤0.01% 2007
2019
Q1 		– Sell
-1,200
Closed -$6.84K – 4687
2018
Q4 		$5K Sell
1,200
-200
-14% -$1.1K ﹤0.01% 2942
2018
Q3 		$11K Sell
1,400
-100
-7% -$713 ﹤0.01% 2608
2018
Q2 		$10K Buy
+1,500
New +$14.7K ﹤0.01% 2685

Other funds holding SNDX

APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return